[A new method of treating tubal pregnancy using prostaglandin F2a and E2].
The present paper reports on the treatment of 30 tubal pregnancies verified by laparoscopy by means of intratubal prostaglandin (PG) F2a and systemic PG E2. Tubal pregnancy was successfully treated in 25 patients; three patients exhibited side effects. The comparison with surgical management showed better results concerning the tubal patency in the PG-treated group. Further studies should clarify whether this technically simple procedure is superior to the existing methods.
Egarter
C
C
I. Universitäts-Frauenklinik Wien, Osterreich.
Fitz
R
R
Husslein
P
P
D006063:Chorionic Gonadotropin / Q000097:blood; D018997:Chorionic Gonadotropin, beta Subunit, Human; D015237:Dinoprost / Q000008:administration & dosage*; D015232:Dinoprostone / Q000008:administration & dosage*; D005187:Fallopian Tubes / Q000187:drug effects; D005260:Female; D006801:Humans; D007267:Injections; D010535:Laparoscopy; D010446:Peptide Fragments / Q000097:blood; D011247:Pregnancy; D011274:Pregnancy, Tubal / Q000188:drug therapy*
D006063:Chorionic Gonadotropin; D018997:Chorionic Gonadotropin, beta Subunit, Human; D010446:Peptide Fragments; D015237:Dinoprost; D015232:Dinoprostone
Neue Behandlungsmethode der Tubargravidität durch Prostaglandin F2a und E2.